Partner With Us
Different Technologies. Different Starting Points. One Translational Objective.
Decinova works with biotechnology companies, investors, academic institutions, hospitals and research organizations seeking to advance cell and regenerative-medicine technologies — above all, DSC and its lead program in steroid-refractory acute GVHD.
Partnership Opportunities
Ways to Partner With Decinova
DSC Licensing & Co-Development
Global or regional licensing and co-development structures to advance DSC in SR-aGVHD and its broader platform potential.
Strategic Investment
Investment structures to accelerate DSC through its next controlled clinical-development stage and toward broader regulatory and commercial development.
Manufacturing Collaboration
Manufacturing partnerships supporting scale-up, CMC readiness and broader development infrastructure.
Technology Transfer
Transfer of Decinova’s stromal-cell and cell-technology know-how into a partner’s own facility.
See Technology Development →Research & Scientific Collaboration
Scientific and translational collaboration exploring DSC biology, mechanism and adjacent applications.
Commercialization Partnerships
Partnerships supporting a scalable pathway toward broader geographic development and commercialization of DSC.
Looking for paid development or technology-build support for your own program rather than a DSC partnership? Visit Development Services or Technology Development.
Audience-Specific Pathways
Start the Right Conversation
Pharma & Biotech Partners
Explore licensing, co-development or clinical-development collaboration on DSC.
Start a licensing conversation →Investors
Discuss strategic investment in Decinova’s next DSC development stage.
Discuss investment →Manufacturing Partners
Explore manufacturing collaboration and scale-up capacity.
Discuss manufacturing →Academic & Research Institutions
Propose scientific or translational research collaboration.
Propose a collaboration →Let’s Move Cell Therapy Forward.
Tell us about your organization and the type of partnership you’re exploring — we’ll route it to the right conversation.